Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist plus hormone replacement therapy versus hormone replacement therapy for frozen embryo transfer in women with polycystic ovarian syndrome
IRCT20090526001952N15Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of estradiol valerate + dydrogesterone in infertility and polycystic ovary syndrome (PCOS) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Endometrial thickness on the day of transfer, Chemical pregnancy and 3 more. Started Jun 2021; status: completed.
02
Drugs
estradiol valerate + dydrogesterone
03
Conditions
infertilitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20090526001952N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090526001952N15.